S&P: Trump Administration Could Be a Net Negative for Health Care Industry
-
Dec 13, 2024
While many upcoming health care policies remain unclear, potential changes brought about by the Trump administration will be a net negative credit-wise for the industry, according to an S&P Global Ratings analyst.
In a Dec. 2 article, analyst Arthur Wong named the top five developments S&P Global is watching: the Affordable Care Act, Medicare drug pricing negotiations in the Inflation Reduction Act (IRA), the Federal Trade Commission’s (FTC) tone on mergers and acquisitions (M&A) and tariffs, and HHS priorities. “We do not envision any rating changes due to the change in administration until it becomes clear what policies will be implemented and their time frame,” Wong wrote. “However, we see more downside than upside risk to ratings over the near term.”
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.